Phase 1 12 trials
Phase 1
NCT07214922 Jan → Feb 2023 —
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
No outcome recorded
Phase 1
NCT07214935 Nov 2022 → Aug 2023 —
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
No outcome recorded
Phase 1
NCT05245396 Feb 2022 → Feb 2023 —
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
No outcome recorded
Phase 1
NCT05248945 Jan → Jul 2022 —
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
No outcome recorded
Phase 1
NCT05064488 Oct → Dec 2021 —
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
No outcome recorded
Phase 1
NCT04697511 Jan → Feb 2021 —
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
No outcome recorded
Phase 1
NCT04546789 Sep 2020 → May 2021 —
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
No outcome recorded
Phase 1
NCT04314024 May → Jun 2020 —
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
No outcome recorded
Phase 1
NCT03934502 Apr → Jun 2019 —
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
No outcome recorded
Phase 1
NCT03725072 Oct → Dec 2018 —
Merck KGaA, Darmstadt, Germany
Completed
No outcome recorded
Phase 1
NCT03436394 Mar 2018 → Feb 2019 impaired renal function disease Merck KGaA, Darmstadt, Germany
Completed
No outcome recorded
Phase 1
NCT02537028 Nov 2015 → Oct 2016 systemic lupus erythematosus EMD Serono Research & Development Institute, Inc.
Completed
No outcome recorded
Show 2 more trials Phase 2 4 trials
Phase 2
NCT03233230 Sep 2017 → Sep 2019 rheumatoid arthritis EMD Serono Research & Development Institute, Inc.
Completed
No outcome recorded
Phase 2
NCT02975349 Mar 2017 → Jan 2018 relapsing-remitting multiple sclerosis EMD Serono Research & Development Institute, Inc.
Terminated
No outcome recorded
Phase 2
NCT02975336 Jan 2017 → Nov 2019 systemic lupus erythematosus EMD Serono Research & Development Institute, Inc.
Terminated
No outcome recorded
Phase 2
NCT02784106 Jul 2016 → Apr 2017 rheumatoid arthritis EMD Serono Research & Development Institute, Inc.
Completed
No outcome recorded
Phase 3 4 trials
Phase 3
NCT04338061 Jul 2020 → Oct 2023 multiple sclerosis Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Terminated
No outcome recorded
Phase 3
NCT04338022 Jun 2020 → Oct 2023 relapsing-remitting multiple sclerosis Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Terminated
No outcome recorded
Phase 3
NCT04032171 Sep 2019 → May 2020 relapsing-remitting multiple sclerosis EMD Serono Research & Development Institute, Inc.
Terminated
No outcome recorded
Phase 3
NCT04032158 Aug 2019 → Apr 2020 relapsing-remitting multiple sclerosis EMD Serono Research & Development Institute, Inc.
Terminated
No outcome recorded